🇺🇸 FDA
Patent

US 9504745

Compositions and methods for cancer treatment using targeted carbon nanotubes

granted A61KA61K38/1709A61K41/0052

Quick answer

US patent 9504745 (Compositions and methods for cancer treatment using targeted carbon nanotubes) held by The Board of Regents of the University of Oklahoma expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K38/1709, A61K41/0052, A61K45/06, A61K47/60